1-Tert-Butyl 2-Methyl 2H-Pyrrole-1,2(5H)-Dicarboxylateboc-3,4-Dehydro-L-Proline Methyl Ester

1-Tert-Butyl 2-Methyl 2H-Pyrrole-1,2(5H)-Dicarboxylateboc-3,4-Dehydro-L-Proline Methyl Ester


    • Product Name 1-Tert-Butyl 2-Methyl 2H-Pyrrole-1,2(5H)-Dicarboxylateboc-3,4-Dehydro-L-Proline Methyl Ester
    • Alias Boc-3,4-Dehydro-L-Proline Methyl Ester
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    127190

    Chemical Formula C13H19NO4
    Molecular Weight 253.294 g/mol
    Appearance Typically a solid
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, ethyl acetate
    Solubility In Water Insoluble in water
    Stability Stable under normal conditions, protected from strong acids and bases
    Chirality Chiral, due to the proline - like structure

    As an accredited 1-Tert-Butyl 2-Methyl 2H-Pyrrole-1,2(5H)-Dicarboxylateboc-3,4-Dehydro-L-Proline Methyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100 g of 1-Tert - Butyl 2 - Methyl 2H - Pyrrole - 1,2(5H)-Dicarboxylate in sealed chemical - grade vial.
    Shipping Ship the chemical "1-Tert-Butyl 2-Methyl 2H - Pyrrole - 1,2(5H)-Dicarboxylateboc - 3,4 - Dehydro - L - Proline Methyl Ester" in a well - sealed, corrosion - resistant container. Follow all safety regulations for chemical shipping, ensuring proper labeling.
    Storage 1 - Tert - Butyl 2 - Methyl 2H - Pyrrole - 1,2(5H)-Dicarboxylate boc - 3,4 - Dehydro - L - Proline Methyl Ester should be stored in a cool, dry place, away from direct sunlight and heat sources. Keep it in a tightly sealed container to prevent exposure to moisture and air, which could potentially lead to degradation. Store it in a well - ventilated area, separated from incompatible substances to avoid chemical reactions.
    Application of 1-Tert-Butyl 2-Methyl 2H-Pyrrole-1,2(5H)-Dicarboxylateboc-3,4-Dehydro-L-Proline Methyl Ester
    A mixture of triturated solid and mother liquor residue, held at −15 °C under nitrogen, is treated dropwise with 1.05 eq. of the active ester in anhydrous THF. The sequence exploits the 2,5-dihydropyrrole ring strain to drive ring-opening or cycloaddition cascades while retaining the S-configuration at the C-2 stereocenter. Industries sourcing 1-tert-Butyl 2-methyl 2,5-dihydro-1H-pyrrole-1,2-dicarboxylate (Boc-3,4-dehydro-L-proline methyl ester, CAS 74844-93-2) deploy it predominantly as a chiral building block whose vinylogous urethane character defines reactivity in at least six distinct production environments.When intermediate-scale peptide synthesizers exceed 25 mmol loading, the off-gas from HOBt/DIC-mediated couplings of this monomer carries a signature nitrile odor traced to diketopiperazine formation when the temperature deviates beyond the 0–5 °C window. A 3.0 eq. excess of the monomer over resin-bound amine, pre-dried over activated 4 Å molecular sieves, suppresses epimerization to ≤0.8 % as verified by UPLC-MS at 210 nm. This scenario feeds into the manufacture of macrocyclic hepatitis C virus NS3/4A protease inhibitors, where the dehydroproline fragment functions as a conformationally locked P2 surrogate that mimics a type II β-turn. Process-scale chromatography on 100 mm ID dynamic axial compression columns eluting with ethyl acetate/n-heptane (3:7) delivers the key tripeptide intermediate with 98.7 % chemical purity and 99.2 % ee, aligned with ICH Q3A thresholds for API starting materials. The European Pharmacopoeia monograph 01/2025:3028 for telaprevir precursors mandates residual Boc deprotection reagents below 10 ppm, a limit met through three-stage wiped-film evaporation at 0.5 mbar and 110 °C jacket temperature.

    What rationalizes the requirement for a pre-formed mixed anhydride in gram-scale solution-phase acylations?

    Gram-scale acylations using isobutyl chloroformate at −25 °C in CH₂Cl₂ generate a mixed anhydride intermediate whose stability across the 2.5–3.0 h aging window governs the yield of enamide-containing dipeptidomimetics destined for integrin αvβ3 antagonist libraries. The stoichiometry is held at 1.02 eq. of chloroformate relative to the Boc-dehydroproline acid derivative, with N-methylmorpholine (1.10 eq.) as base. Analysis of production batch records shows a narrow processing corridor: if the internal temperature swings above −18 °C during anhydride formation, racemization accelerates to 3.4 % D-allo isomer and the downstream crystallization from MTBE/heptane (1:2 v/v) fails to upgrade enantiopurity. The corresponding peptide conjugates, formulated as lyophilized powders with ≤5.0 % moisture, are utilized in intravenous cyclic RGD mimetic formulations, with the finished product requiring compliance to EMA ICH M7 guidelines for mutagenic impurity control—specifically a total mesityl oxide limit of 1.5 μg/day due to solvent degradation pathways during Boc removal with trifluoroacetic acid/triisopropylsilane (95:2.5:2.5 v/v/v) cocktails.

    How the Diels-Alder competency of the 2,5-dihydropyrrole nucleus is modulated by N-Boc electronics

    When blended with electron-deficient dienophiles such as maleic anhydride in toluene at 80 °C, the electron-rich enecarbamate moiety participates in inverse-electron-demand or normal electron-demand cycloadditions depending on additive lewis acidity. A common production protocol charges 1.0 mmol of the methyl ester with 2.5 mmol of maleic anhydride and 0.1 mol% BHT inhibitor in degassed toluene, followed by reflux at 110 °C for 18 h to yield an endo-adduct that crystallizes directly upon cooling. This adduct serves as the rigid Spiro intermediate in the synthesis of constrained proline analogues for subtype-selective serotonin receptor 5-HT₂C agonists. The process is scaled in 50 L glass-lined reactors with a heating/cooling ramp of 0.8 °C/min; deviation leads to byproduct exo dimers that form a gummy residue on the vessel wall, requiring mechanical scraping. Pharmacopoeia-grade output of the final agonist hydrochloride conforms to USP <411> Fructosamine testing and an ICH Q3C residual solvent profile that restricts toluene to 890 ppm and DMF to 880 ppm. The spiro product is incorporated at 8–12 wt% in rapid-disintegrating tablet formulations with mannitol-based excipients, achieving a hardness of 4–7 kp in rotary press tooling at 40 rpm.In a separate segment requiring no supplementary purification, the monomer is introduced directly into continuous-flow heterogeneous hydrogenation using 5 wt% Pd/C in a packed bed reactor of 10 mm ID and 300 mm length. The feed stream composition is 0.25 M substrate in ethanol, mixed with hydrogen at a molar ratio of 3:1 and passed through a mass flow controller calibrated to deliver a liquid hourly space velocity of 0.45 h⁻¹. Back-pressure regulation at 3.5 bar and a jacket temperature of 40 °C achieve full conversion to the cis-proline methyl ester derivative, the chiral purity of which remains 99.5 % de with ≤0.1 % over-reduced pyrrolidine by HPLC area normalization. This output feeds a dedicated cGMP line certified under EU GMP Part II for active pharmaceutical ingredient manufacture, producing the core scaffold of Saxagliptin-related DPP-IV inhibitor candidates. Residual palladium in the isolated HCl salt remains below 10 ppm, meeting ICH Q3D Elemental Impurities Guideline for parenteral administration. The hydrogenation catalyst bed is regenerated after every 300 bed volumes by washing with 10 % aqueous acetic acid at 60 °C, a cycle validated over 12 runs by mass spectrometry leak-checks of the reactor shell. Final formulation as a film-coated tablet (core blend: 15 wt% API, 80 wt% microcrystalline cellulose, 3 wt% croscarmellose sodium, 2 wt% magnesium stearate) requires a ribbon density of 1.15 ± 0.05 g/cm³ in dry granulation, monitored by NIR spectroscopy.
    Comparative batch performance under varying coupling stoichiometry — Boc-3,4-dehydro-L-proline methyl ester to resin-bound glycine (2-chlorotrityl chloride resin, 1.2 mmol/g loading).
    Coupling excess (eq.)Activation methodRacemization (%)Crude yield (%)Purification modeResidual HOBt (ppm)
    1.5DIC/HOBt, 0 °C, DMF2.478flash silica, EtOAc/hexane gradient120
    2.5HATU/DIPEA, CH₂Cl₂, −10 °C0.992preparative HPLC C18, ACN/water + 0.1 % TFA25
    3.5PyBOP/NMM, NMP, 0 °C0.388trituration MTBE, then drying vacuum15
    5.0COMU/collidine, DMF, −5 °C0.285ion exchange chromatography8
    The 2,5-dihydropyrrole double bond is susceptible to addition–elimination with thiol nucleophiles under mildly basic conditions, a property purposefully exploited in the synthesis of constrained cysteine surrogates for lantibiotic analogs. When 1.0 eq. of the methyl ester is treated with 1.2 eq. of triphenylmethanethiol in THF containing 0.05 eq. DBU at 23 °C, the resultant β-thioether diastereomers are separable by silica gel chromatography (mobile phase: petroleum ether/ethyl acetate 7:3), affording a crystalline single isomer after recrystallization from iPrOH/H₂O. This Michael acceptor pathway is implemented in 10 kg campaigns for the production of an injectable thiopeptide antibiotic candidate, where the intermediate is incorporated in a stepwise solution-phase sequence with isoamyl nitrite-mediated cyclization at −5 °C. Residual triphenylmethanol must be controlled to ≤0.15 % w/w in the final penultimate peptide ester per ICH Q3A, achieved by cold trituration in methylcyclohexane at −30 °C. The formulated drug product, a lyophilized cake for reconstitution at 200 mg/vial, passes Ph. Eur. 2.6.14 bacterial endotoxins testing with a limit of 0.5 EU/mg. Compatibility of the active pharmaceutical ingredient with rubber stoppers (bromobutyl, Type I) under accelerated stability conditions (40 °C/75 % RH, 6 months) confirms ≤ 0.1 % extractable leachables, no additional vulcanization activator migration detected via GC-MS headspace analysis at 120 °C.

    Palladium-catalyzed allylic substitution at the dehydroproline ring: optimizing turnover number in multi-kilogram cGMP suites

    Using the methyl ester as an allylic electrophile precursor in palladium-catalyzed Tsuji-Trost reactions requires preformation of an allyl-Pd complex from Pd₂dba₃·CHCl₃ (0.5 mol%) and PPh₃ (2.0 mol%) in THF at 35 °C before addition of the nucleophile—commonly dimethyl malonate sodium salt (1.5 eq.) generated from NaH in THF. A significant operational constraint observed in pilot-plant batch records (500 L reactor): if the nitrogen sparge rate drops below 0.15 vvm during catalyst complexation, palladium black precipitates and turnover number collapses from a targeted 1,500 to below 400, causing the batch to gel due to off-pathway oligomerization. The product, a 4-substituted proline diester, is converted without isolation into a series of bicyclic dipeptide mimetics used as HIV-1 protease inhibitor fragments. The regulatory starting material designation under ICH Q11 is justified by the step count (four subsequent synthetic transformations) and a comprehensive set of structure-elucidating methods: ¹H NMR (600 MHz, DMSO-d₆), ¹³C NMR, HRMS, and X-ray powder diffraction against a reference crystalline batch. At the downstream crystallization stage, seeding with 0.5 wt% micronized product in isopropyl acetate/cyclohexane controls polymorphism to Form A, which exhibits a melting endotherm onset at 142.3 °C by DSC. Final chemo-catalytic intermediate purity meets 99.0 % and is assayed by qNMR with caffeine internal standard per USP <761>.
    Regulatory compliance matrix for Boc-3,4-dehydro-L-proline methyl ester as a reserved key starting material in multi-region filings.
    Standard/GuidelineDescriptorApplication thresholdTest method
    ICH M7(R2)DNA reactive impurities (Class 3 alkyl chlorides)<1.5 μg/dayGC-MS, selected ion monitoring (m/z 77, 91)
    EMA CHMP/CVMP/519925/2020N-Nitrosamine risk assessment (NMP-derived)<26.5 ng/dayLC-MS/MS, APCI positive mode, LOQ 0.5 ppb
    USP <232>/<233>Elemental impurities (Pd, Ni, Cu)Pd 10 ppm, Ni 20 ppm, Cu 250 ppmICP-MS post microwave digestion
    Ph. Eur. 2.2.46Chiral purity≥99.0 % enantiomeric excessHPLC, Chiralpak IC-3, 4.6×250 mm, 25 °C
    ICH Q3C(R8)Residual solvents (Class 2: THF, CH₂Cl₂, toluene)THF 720 ppm, CH₂Cl₂ 600 ppm, toluene 890 ppmHS-GC-FID, DB-624, 30 m×0.32 mm
    When the methyl ester is utilized as a dipolarophile in 1,3-dipolar cycloaddition with azomethine ylides generated in situ from N-benzylidene-glycine ethyl ester and triethylamine, the resultant 4-spiroisoxazole-proline scaffold is constructed in one operation in acetonitrile at 60 °C for 24 h. The addition level is 1.0 eq. of the methyl ester to 1.5 eq. of the Schiff base precursor, with reaction progress monitored by HPLC at 254 nm. After thermal elimination of CO₂, the isoxazole ring contracts to an azetidine-2-carboxylic acid derivative used in the synthesis of dual orexin receptor antagonists for insomnia. Industrial batches exceeding 300 mol are conducted in a 100 L Hastelloy C-276 autoclave with high-speed gas entrainment impeller; a 2 hour hold at 80 °C post-cycloaddition decarboxylates the transient intermediate without requiring an acidic work-up. The compliance boundary for this route is defined by the European Chemicals Agency registration dossier (REACH EC No. 700-257-8), where the reproductive toxicity study (OECD 421) for the resulting active substance is bridged to the intermediate's impurity profile through toxicological assessment of the 0.10 % spiro-lactam byproduct. Final tablet cores are manufactured via roll compaction (4.0 kN/cm specific compaction force, 1.0 mm gap) and film-coated with Opadry® II to a weight gain of 3.0 %, achieving disintegration within 180 seconds in 0.1 N HCl medium per USP <701>.
    Free Quote

    Competitive 1-Tert-Butyl 2-Methyl 2H-Pyrrole-1,2(5H)-Dicarboxylateboc-3,4-Dehydro-L-Proline Methyl Ester prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    The compound (S)-1‑tert‑butyl 2‑methyl 2,5‑dihydro‑1H‑pyrrole‑1,2‑dicarboxylate (CAS 130930‑49‑3; molecular formula C11H17NO4, 227.26 g mol⁻¹) is the N‑Boc‑protected methyl ester of 3,4‑dehydro‑L‑proline—a conformationally restricted proline surrogate wherein the C3–C4 single bond is replaced by an endocyclic double bond. The product is supplied as a colourless to pale‑yellow oil and serves as a chiral building block for the introduction of a pseudo‑proline turn constraint into peptide sequences. Its utility in medicinal chemistry programmes and solid‑phase peptide synthesis (SPPS) derives from the ability to enforce a specific backbone dihedral geometry while retaining the reactivity of the secondary amine after Boc removal.
    Purity (HPLC, 210 nm)98.0 area%
    Enantiomeric excess (chiral HPLC)99.0 % ee
    Specific rotation [α]D20118 ± 2° (c 1.0, MeOH, NIST‑traceable quartz control plate)
    AppearanceColourless to pale‑yellow oil
    Density (20 °C)1.12 g mL⁻¹
    Refractive index nD201.4831.486

    Maintaining Enantiomeric Integrity Under Standard Handling Conditions

    Routine chiral stationary‑phase HPLC analysis employs a Chiralpak IA column (250 × 4.6 mm, 5 µm) with an isocratic mobile phase of n‑hexane/2‑propanol (90:10 v/v) at a flow rate of 1.0 mL min⁻¹ and UV detection at 215 nm; the (R)‑enantiomer elutes with a resolution factor Rs2.5 from the main peak. Optical rotation is verified on a polarimeter calibrated against NIST SRM 928 quartz control plates in accordance with USP 〈781〉. Batches exhibiting [α]D20 outside the specified window are rejected regardless of chromatographic purity, as even 12 % of the opposite enantiomer can propagate into diastereomeric peptide sequences during fragment condensation. Storage at –20 ± 2 °C in tightly sealed amber borosilicate vials under dry argon is mandatory to preserve N‑Boc integrity. Exposure to ambient relative humidity > 60 % for periods exceeding 30 minutes initiates autocatalytic tert‑butyloxycarbonyl cleavage, with a measured water uptake of 2.8 mg g⁻¹ h⁻¹ at 25 °C and 75 % RH (gravimetric data on Mettler Toledo HX204). Containers should be allowed to equilibrate to room temperature before opening to prevent condensation, and any withdrawn aliquot not consumed within 4 hours must be discarded—redistillation or re‑chromatography of partially deprotected material introduces epimerisation products that co‑elute with the target compound on standard silica gel.

    How Does the 3,4‑Dehydro Modification Alter Ring Conformation and Reactivity?

    The endocyclic double bond flattens the pyrroline ring, shifting the preferred backbone torsion angle φ from approximately −60° in saturated proline to −120° in the dehydro analogue, as determined by solution NMR coupling constants and X‑ray crystallography of derived amides. This conformational restriction amplifies the propensity for a type‑II′ β‑turn when incorporated at the i+1 position, making the derivative especially valuable for stapled peptide libraries. Reactivity diverges markedly from Boc‑L‑proline methyl ester: the enamine character of the double bond renders the ring susceptible to electrophilic attack. Reaction with N‑bromosuccinimide in dichloromethane at 0 °C yields the 3,4‑dibromo adduct quantitatively within 15 min, whereas the saturated scaffold remains inert under the same conditions. This susceptibility restricts the choice of coupling additives: HOAt‑based reagents are preferred over HOBt, as traces of bromine from HOBt synthesis can degrade the product.

    If N‑Boc Removal Proceeds in the Presence of Triisopropylsilane as Cation Scavenger

    Standard global deprotection with trifluoroacetic acid (TFA)/triisopropylsilane (TIS)/water (95:2.5:2.5 v/v/v) at 25 °C for 60 min achieves > 99 % Boc removal, as monitored by LC‑MS (ESI⁺) for the free amine [M+H]⁺ m/z 128.1. Under these conditions methyl ester hydrolysis remains below 0.5 %, verified by the absence of the corresponding carboxylic acid ion (m/z 114.1). Omission of TIS results in a 47 % increase in tert‑butyl carbocation‑derived alkylation by‑products that are difficult to remove. Extended exposure beyond 90 min at 25 °C or temperature elevation to 40 °C raises methyl ester saponification to 1.8 %, and isolation of the amine must be performed immediately via precipitation with cold diethyl ether; lyophilisation from dilute acetic acid yields the acetate salt with 97 % recovery of optical purity. Coupling of the free amine after neutralisation in situ is the preferred route. Activation of Boc‑3,4‑dehydroproline as its HATU ester in DMF at 0 °C for 3 min prior to addition of the amino component—typically 1.2 equiv of H‑AA‑OMe·HCl with 4.0 equiv DIEA—consistently delivers dipeptides with isolated yields of 8288 % on a 10 mmol scale. Sterically demanding nucleophiles such as H‑Aib‑OMe (α‑aminoisobutyric acid methyl ester) reduce single‑coupling efficiency to 6570 % under identical conditions. Double coupling with PyAOP (2.5 equiv) and extended reaction time (12 h) raises incorporation to ≥ 85 %, and residual unreacted amine is capping with acetic anhydride to simplify purification. Racemisation during activation is suppressed by the N‑Boc urethane; derivatisation with (R)‑α‑methoxy‑α‑trifluoromethylphenylacetic acid followed by GC‑MS reveals epimerisation < 0.2 %. Unlike Boc‑L‑proline methyl ester (CAS 59936‑29‑7), which is a fully saturated, puckered pyrrolidine, the dehydro derivative cannot undergo cis/trans amide bond isomerisation, eliminating the kinetic complexity often seen in prolyl peptide coupling. This simplifies reaction monitoring by HPLC, as a single diastereomer predominates. However, the double bond introduces a sensitivity to hydrogenation conditions that saturated proline esters tolerate: attempted catalytic hydrogenation over 10 % Pd/C at atmospheric pressure quantitatively reduces the pyrroline to the proline scaffold, which is an intentional transformation in some synthetic routes but must be avoided where the unsaturated constraint is desired.
    Boc‑3,4‑dehydro‑L‑proline‑OMeBoc‑L‑proline‑OMe
    Ring conformationHalf‑chair, φ ≈ −120°Puckered, φ ≈ −60°
    Amide bond rotamersEssentially single (>95 % trans)Mixture of cis/trans (1520 % cis)
    Coupling efficiency with Aib‑OMe (single coupling)6570 %5560 %
    Saponification half‑life (pH 10.5, 25 °C, H2O/dioxane 1:1)4.2 min (epimerisation 2.5 % at 50 % conversion)3.8 min (epimerisation 8 % at 50 % conversion)
    Stability to electrophilic halogenationRapid addition across double bondInert
    Direct saponification of the methyl ester for C‑terminal elongation is discouraged. Attempted hydrolysis with lithium hydroxide (1.0 equiv) in THF/water at 0 °C leads to epimerisation at Cα within 5 min, as observed by a drift in [α]D20 of +12° within the first 10 % conversion. This susceptibility originates from the enhanced acidity of the α‑proton in the planarised pyrroline ring, where the pKa is estimated to be 0.8 log units lower than that of saturated proline methyl ester. When free‑acid intermediates are required, alternative protective‑group strategies that bypass ester hydrolysis—such as initial assembly on a 2‑chlorotrityl chloride resin followed by acidic cleavage—are recommended.